Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06785467 · ClinicalTrials.gov registry record · NA
eDoula Feasibility and Acceptability
A NA study of Pregnancy Related, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06785467: Recruiting NA study of Pregnancy Related, sponsored by Oregon Health and Science University.
NCT06785467 is a NA study of Pregnancy Related that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 60 participants, below the 1,962-participant average among 99 other Pregnancy Related trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06785467, a NA study of Pregnancy Related, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
eDoula is an app that will give patients reading material and videos to watch based on their due date. It also provides helpful postpartum guidance. First, patients without access to the app will be recruited and surveyed on their labor and satisfaction outcomes. Then, recruitment will begin for the intervention arm of the study. Participants will be recruited to use the app and complete a survey during the postpartum period.
Primary Outcome
Participant-reported satisfaction with the eDoula app using a 3-question Likert scale. Scores can have a value from 3 to 15, with a higher score indicating greater satisfaction.
Conditions Studied
Interventions
- OTHER eDoula App
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-01-23 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT06785467 shows while recruiting
NCT06785467 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,962-participant average among 99 other Pregnancy Related trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Pregnancy Related appearing as the primary indexed condition, and to 1 intervention - of which eDoula App is the first listed.
NCT06785467 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT06785467 about?
NCT06785467 is a clinical study titled "eDoula Feasibility and Acceptability". eDoula is an app that will give patients reading material and videos to watch based on their due date. It also provides helpful postpartum guidance. First, patients without access to the app will be recruited and surveyed on their labor and satisfaction outcomes. Then, recruitment will begin for the...
What is the current status of trial NCT06785467?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-01-23. Estimated completion is 2026-06.
What conditions does trial NCT06785467 study?
This clinical trial studies the following conditions: Pregnancy Related.
What interventions are being tested in trial NCT06785467?
The interventions under investigation include: eDoula App (OTHER).
Who is sponsoring clinical trial NCT06785467?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06785467 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06785467's enrollment target sits among peer trials
60 65th of 99 higher than 31 of 99 other Pregnancy Related trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Related trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Accountability for Care Through Undoing Racism & Equity for Moms
RECRUITING · NA
-
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
-
MAMA Tot - Healthy Weight Parallel Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI